Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production.

Autor: Tang, Anthony C, Rahavi, Seyed M, Fung, Shan-Yu, Lu, Henry Y, Yang, Hong, Lim, Chinten J, Reid, Gregor S, Turvey, Stuart E
Zdroj: Cell Death & Disease; Feb2018, Vol. 9 Issue 2, p1-1, 1p
Databáze: Complementary Index